-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Crescent Capital BDC, Lowers Price Target to $19

Benzinga·11/14/2025 17:22:23
Listen to the news
Oppenheimer analyst Mitchel Penn maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and lowers the price target from $20 to $19.